Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 538

1.

Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.

Bocchetta S, Maillard P, Yamamoto M, Gondeau C, Douam F, Lebreton S, Lagaye S, Pol S, Helle F, Plengpanich W, Guérin M, Bourgine M, Michel ML, Lavillette D, Roingeard P, le Goff W, Budkowska A.

PLoS One. 2014 Mar 19;9(3):e92140. doi: 10.1371/journal.pone.0092140. eCollection 2014.

2.

LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.

Kannisto K, Gåfvels M, Jiang ZY, Slätis K, Hu X, Jorns C, Steffensen KR, Eggertsen G.

Lipids. 2014 Jan;49(1):71-83. doi: 10.1007/s11745-013-3853-8. Epub 2013 Oct 27.

PMID:
24163219
3.

Extracellular lipid-free apolipoprotein E inhibits HCV replication and induces ABCG1-dependent cholesterol efflux.

Crouchet E, Lefèvre M, Verrier ER, Oudot MA, Baumert TF, Schuster C.

Gut. 2017 May;66(5):896-907. doi: 10.1136/gutjnl-2015-311289. Epub 2016 Sep 8.

4.

The LXR ligand GW3965 inhibits Newcastle disease virus infection by affecting cholesterol homeostasis.

Sheng XX, Sun YJ, Zhan Y, Qu YR, Wang HX, Luo M, Liao Y, Qiu XS, Ding C, Fan HJ, Mao X.

Arch Virol. 2016 Sep;161(9):2491-501. doi: 10.1007/s00705-016-2950-4. Epub 2016 Jun 29.

PMID:
27357231
5.

(-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.

Calland N, Albecka A, Belouzard S, Wychowski C, Duverlie G, Descamps V, Hober D, Dubuisson J, Rouillé Y, Séron K.

Hepatology. 2012 Mar;55(3):720-9. doi: 10.1002/hep.24803.

PMID:
22105803
6.

Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner.

Zeng J, Wu Y, Liao Q, Li L, Chen X, Chen X.

Antiviral Res. 2012 Sep;95(3):245-56. doi: 10.1016/j.antiviral.2012.06.004. Epub 2012 Jun 17.

PMID:
22713431
7.

Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells.

Anggakusuma, Colpitts CC, Schang LM, Rachmawati H, Frentzen A, Pfaender S, Behrendt P, Brown RJ, Bankwitz D, Steinmann J, Ott M, Meuleman P, Rice CM, Ploss A, Pietschmann T, Steinmann E.

Gut. 2014 Jul;63(7):1137-49.

PMID:
23903236
8.

Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C.

Schaefer EA, Meixiong J, Mark C, Deik A, Motola DL, Fusco D, Yang A, Brisac C, Salloum S, Lin W, Clish CB, Peng LF, Chung RT.

World J Gastroenterol. 2016 Dec 7;22(45):9954-9965. doi: 10.3748/wjg.v22.i45.9954.

9.

Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles.

Haid S, Pietschmann T, Pécheur EI.

J Biol Chem. 2009 Jun 26;284(26):17657-67. doi: 10.1074/jbc.M109.014647. Epub 2009 May 1.

10.

Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.

Lin LT, Chung CY, Hsu WC, Chang SP, Hung TC, Shields J, Russell RS, Lin CC, Li CF, Yen MH, Tyrrell DL, Lin CC, Richardson CD.

J Hepatol. 2015 Mar;62(3):541-8. doi: 10.1016/j.jhep.2014.10.040. Epub 2014 Nov 4. Erratum in: J Hepatol. 2015 Jul;63(1):292.

PMID:
25450204
11.

Expression of human factors CD81, claudin-1, scavenger receptor, and occludin in mouse hepatocytes does not confer susceptibility to HCV entry.

Hikosaka K, Noritake H, Kimura W, Sultana N, Sharkar MT, Tagawa Y, Uezato T, Kobayashi Y, Wakita T, Miura N.

Biomed Res. 2011 Apr;32(2):143-50.

12.

Lipids: a key for hepatitis C virus entry and a potential target for antiviral strategies.

Blaising J, Pécheur EI.

Biochimie. 2013 Jan;95(1):96-102. doi: 10.1016/j.biochi.2012.07.016. Epub 2012 Aug 1. Review.

PMID:
22884392
13.

Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux.

Jiang H, Badralmaa Y, Yang J, Lempicki R, Hazen A, Natarajan V.

Lipids Health Dis. 2012 Jul 9;11:69. doi: 10.1186/1476-511X-11-69.

14.

ATP-binding cassette transporter A1 mediates the beneficial effects of the liver X receptor agonist GW3965 on object recognition memory and amyloid burden in amyloid precursor protein/presenilin 1 mice.

Donkin JJ, Stukas S, Hirsch-Reinshagen V, Namjoshi D, Wilkinson A, May S, Chan J, Fan J, Collins J, Wellington CL.

J Biol Chem. 2010 Oct 29;285(44):34144-54. doi: 10.1074/jbc.M110.108100. Epub 2010 Aug 25.

15.

MicroRNA-101 overexpression by IL-6 and TNF-α inhibits cholesterol efflux by suppressing ATP-binding cassette transporter A1 expression.

Zhang N, Lei J, Lei H, Ruan X, Liu Q, Chen Y, Huang W.

Exp Cell Res. 2015 Aug 1;336(1):33-42. doi: 10.1016/j.yexcr.2015.05.023. Epub 2015 May 29.

PMID:
26033364
16.

Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.

Anggakusuma, Romero-Brey I, Berger C, Colpitts CC, Boldanova T, Engelmann M, Todt D, Perin PM, Behrendt P, Vondran FW, Xu S, Goffinet C, Schang LM, Heim MH, Bartenschlager R, Pietschmann T, Steinmann E.

Hepatology. 2015 Sep;62(3):702-14. doi: 10.1002/hep.27913. Epub 2015 Jul 28.

PMID:
25999047
17.

ABCA1 upregulating apolipoproein M expression mediates via the RXR/LXR pathway in HepG2 cells.

Di D, Wang Z, Liu Y, Luo G, Shi Y, Berggren-Söderlund M, Nilsson-Ehle P, Zhang X, Xu N.

Biochem Biophys Res Commun. 2012 Apr 27;421(1):152-6. doi: 10.1016/j.bbrc.2012.04.022. Epub 2012 Apr 9.

PMID:
22516753
18.

The mechanism of HCV entry into host cells.

Douam F, Lavillette D, Cosset FL.

Prog Mol Biol Transl Sci. 2015;129:63-107. doi: 10.1016/bs.pmbts.2014.10.003. Epub 2014 Dec 12. Review.

PMID:
25595801
19.

Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.

Zhang F, Sodroski C, Cha H, Li Q, Liang TJ.

Gastroenterology. 2017 Jan;152(1):257-270.e7. doi: 10.1053/j.gastro.2016.09.033. Epub 2016 Sep 30.

20.

CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.

Ishibashi M, Morita N, Nomura-Kawaguchi C, Shimizu Y, Wakita T, Esumi M.

Arch Virol. 2014 Nov;159(11):2949-55. doi: 10.1007/s00705-014-2150-z. Epub 2014 Jun 26.

PMID:
24965233

Supplemental Content

Support Center